Anti-HER2 Single Domain Antibody 2Rs15d Labeled with 18F Using a Residualizing Label: Preliminary Evaluation

被引：0
|
作者：
Vaidyanathan, G. V. [1 ]
Zhou, Z. [1 ]
McDougald, D. [1 ]
Lahoutte, T. [2 ]
Zalutsky, M. R. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Free Univ Brussels, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP594
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [41] The First PET Evaluation of the Fluorine-18 Labeled Dopamine D2/D3 Receptors Agonist, [18F]MCL-524
    Finnema, S. J.
    Stepanov, V.
    Nakao, R.
    Sromek, A. W.
    Zhang, T. Z.
    Neumeyer, J. L.
    George, S. R.
    Seeman, P.
    Farde, L.
    Halldin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S188 - S188
  • [42] Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET
    Mume, E
    Orlova, A
    Malmström, PU
    Lundqvist, H
    Sjöberg, S
    Tolmachev, V
    NUCLEAR MEDICINE AND BIOLOGY, 2005, 32 (06) : 613 - 622
  • [43] Specific targeting of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer cells by polyethylene glycol-grafted polyethyleneimine modified with anti-HER2 single-domain antibody
    Saqafi, Batoul
    Rahbarizadeh, Fatemeh
    JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2018, 33 (01) : 17 - 37
  • [44] Comparative evaluation of anti-HER2 affibody molecules labeled with 68Ga and 111In using maleimido derivatives of DOTA and NODAGA.
    Altai, M.
    Strand, J.
    Rosik, D.
    Selvaraju, R.
    Karlstrom, A. Eriksson
    Orlova, A.
    Tolmachev, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S299 - S299
  • [45] Radiosynthesis and in vitro evaluation of a series of novel homologous [18F]-labeled dopamine D2/3-agonist ligands
    Shalgunov, Vladimir
    Dierckx, Rudi A. J. O.
    Janssen, Henk M.
    Booij, Jan
    Elsinga, Philip H.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S337 - S337
  • [46] Delivery of NKG2D Ligand Using an Anti-HER2 Antibody-NKG2D Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Anti-Tumor Response.
    Shin, S-U
    Cho, H-M
    Tolba, K.
    Shin, S. J.
    Shin, D. S.
    Calfa, C.
    Zhang, Y.
    Rosenblatt, J. D.
    CANCER RESEARCH, 2009, 69 (24) : 857S - 857S
  • [47] Synthesis and PET evaluation of a novel F-18 labeled deuterated fluorodeprenyl ([18F]fluorodeprenyl-D2) radioligand to study MAO-B activity
    Nag, Sangram
    Lehmann, Lutz
    Kettschau, Georg
    Heinrich, Tobias
    Thiele, Andrea
    Varrone, Andrea
    Gulyas, Balazs
    Halldin, Christer
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S101 - S102
  • [48] Preoperative metabolic evaluation of suspected brain tumors on MRI by positron emission tomography using 18F labeled O-(2-18F-fluoroethyl)-L-tyrosine (FET) and 18F FDG.
    Cheon, GJ
    Ahn, SH
    Cho, YS
    Lee, CH
    Kwack, HS
    Choi, CH
    Lim, SM
    Hong, SW
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 249P - 249P
  • [49] Evaluation of patients with round atelectasis using 2-[18F]fluoro-2- deoxy-D-glucose PET
    Department of Radiology, Duke University Medical Center, Box 3808, Durham, NC 27710, United States
    J. Comput. Assisted Tomogr., 4 (601-604):
  • [50] A single-arm, open-label, phase. study investigating anti-HER2 ADC plus anti-PD-1 antibody in patients with unresectable locally advanced or metastatic BTC with HER2 overexpression.
    Chen, Xiaofeng
    Guo, Fen
    Zhang, Xinyi
    Qiu, Jinrong
    Zheng, Tongsen
    Qiu, Hong
    Tian, Yitong
    Pan, Lanlan
    Zhang, Jiaguang
    Chen, Yizhang
    Shen, Haoyang
    Wang, Chao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS619 - TPS619
12345